Rethinking Dosage Optimization in Breast Oncology
At the 2024 San Antonio Breast Cancer Symposium®, a dynamic workshop on Dose Optimization in Breast Medical Oncology shed light on the shift away from how researchers have traditionally determined the dose for a new treatment by a model called maximum tolerated dose (MTD) and instead, use patient-centered approaches that balance effectiveness and quality of life. Moderated by Dr. Mirat […]
Results from the OlympiA Trial on Olaparib for High-Risk Breast Cancer Patients
Results from the OlympiA Trial on Olaparib for High-Risk Breast Cancer Patients Today we were a part of a pivotal moment in breast cancer research at SABCS 2024. The long-term follow-up results from the OlympiA trial, a phase 3, multicenter study, have been shared, bringing new hope for patients with high-risk HER2-negative primary breast cancer who carry […]
Immediate vs. Deferred Breast Surgery in Women Aged 70+
We’re reporting live from the San Antonio Breast Cancer Symposium (SABCS) 2024, where new research is shaping the future of breast cancer care. One of the highlights so far is a study addressing a critical question for women aged 70 and older with operable breast cancer: Is immediate surgery necessary, or can it safely be […]
Mohawk College Students Advancing Breast Cancer Research
Mohawk College Students Advancing Breast Cancer Research Hamilton’s next generation of advertisers are driving groundbreaking research to improve outcomes for breast cancer patients. This holiday season, Breast Cancer Canada is partnering with advertising students from Mohawk College, The Agency, to launch Progress Is Our Gift, a dynamic campaign designed to encourage Canadians to give the […]
Meet the Researcher: Jeri Spilberg
Meet Jeri Spilberg is a MSc student in the Department of Anatomy & Cell Biology at Western University. She is conducting BCC-funded breast cancer research under the mentorship of Dr. Alison Allan. Her research focuses on integrins: proteins that influence how and where cancer spreads, offering new insights into metastasis. Inspired by her grandmother, a […]
The Metastasizing Chair
The Metastasizing Chair Installation Urges Public Action for Early Breast Cancer Detection Breast cancer won’t wait—neither should routine screenings. Toronto, ON, October 30, 2024 – Breast Cancer Canada proudly unveils The Metastasizing Chair installation at Union Station, an evocative artistic expression that sparks essential conversations about the critical need for early breast cancer detection. Open […]
2024 Progress Report on Breast Cancer
Breast Cancer Canada has released the 2024 Progress Report on Breast Cancer This first-of-its-kind report, with evidence from the public, patients, and expert specialists, provides a comprehensive evaluation of breast cancer care across the country. The Progress Report identifies urgent gaps in care and offers actionable insights and equitable policy recommendations to guide health system stakeholders to improve […]
Recommendations for HER2+ Breast Cancer Treatment
Understanding Recommendations for HER2+ Breast Cancer Treatment in Canada HER2-positive (HER2+) breast cancer is a more aggressive form of breast cancer, affecting about 14% of patients. Thankfully, breakthroughs in targeted therapies over the years have improved outcomes for those living with this condition. But even with these advances, gaps remain in how treatments are provided […]
Join Us at the Canadian Reception at SABCS
Breast Cancer Canada is excited to host an exclusive evening of networking and national research announcements at the San Antonio Breast Cancer Symposium. We warmly invite Canadian oncologists, researchers, and industry leaders to connect with peers, share insights, and explore the latest advancements in breast cancer progress. Canadian Reception Wednesday, December 11th, 2024 at 5:30 […]
Queens Park: Breast Cancer Canada Calls on Ontarians
Self-Refer for Mammograms as Screening Age Lowers to 40 This pivotal change expands access to life-saving mammograms for millions of women in Ontario, empowering them to make informed health decisions and detect cancers at their most treatable stage. From left to right: Shaniah Leduc (Board Chair, Breast Cancer Canada), MPP Laura Smith, and Kimberly Carson […]
